Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Down Following Analyst Downgrade

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) gapped down before the market opened on Friday after Truist Financial lowered their price target on the stock from $10.00 to $9.00. The stock had previously closed at $6.34, but opened at $6.03. Truist Financial currently has a hold rating on the stock. Aveanna Healthcare shares last traded at $6.44, with a volume of 496,743 shares traded.

A number of other analysts also recently commented on AVAH. William Blair initiated coverage on Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating for the company. UBS Group increased their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Finally, Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $10.94.

Insiders Place Their Bets

In related news, insider Patrick A. Cunningham sold 18,436 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $132,923.56. Following the completion of the sale, the insider directly owned 337,755 shares in the company, valued at $2,435,213.55. This trade represents a 5.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the completion of the sale, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. This trade represents a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 998,595 shares of company stock valued at $7,567,770. 7.80% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results materially beat estimates — Aveanna reported revenue of $662.5M (up ~27% YoY) and an EPS beat (reported $0.83 vs. consensus near $0.13). The strong top‑line growth and big EPS beat are the main bullish catalysts. GlobeNewswire Q4 Results
• Positive Sentiment: Raymond James upgraded AVAH from Outperform to Strong‑Buy and set a $13 price target (~~97% above the recent price), which likely boosted investor demand and sentiment. Finviz (Raymond James Upgrade)
• Neutral Sentiment: Earnings call / transcripts available for detail — Investors can review management’s commentary on margins, organic growth and reimbursement trends in the Q4 call transcript to assess sustainability of recent results. Earnings Call Transcript
• Neutral Sentiment: Short‑interest data in recent reports appears unreliable/zeroed out (reported as 0 shares), so it doesn’t provide a clear signal on positioning or potential squeezes at the moment.
• Negative Sentiment: Fiscal‑2026 revenue/growth outlook disappointed some analysts and investors — coverage noted that the company’s revenue outlook trailed consensus, which pressured the stock despite the Q4 beat. That guidance miss is the main bearish offset to today’s gains. MSN (Guidance Miss)
• Negative Sentiment: Some outlets flagged the fiscal‑2026 guidance update as a reason for intracday weakness after the initial pop, highlighting that near‑term growth assumptions and reimbursement dynamics will be key watchpoints for investors. TipRanks (Guidance & Outlook)

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd boosted its stake in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares during the period. Quantbot Technologies LP acquired a new position in Aveanna Healthcare in the 2nd quarter valued at $43,000. Lion Street Advisors LLC bought a new stake in shares of Aveanna Healthcare during the 3rd quarter valued at $89,000. EverSource Wealth Advisors LLC grew its holdings in shares of Aveanna Healthcare by 88,100.0% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after purchasing an additional 11,453 shares in the last quarter. Finally, State of Alaska Department of Revenue bought a new position in shares of Aveanna Healthcare in the third quarter worth $106,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Stock Performance

The firm has a market cap of $1.37 billion, a price-to-earnings ratio of 18.16 and a beta of 2.07. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a 50 day moving average of $7.88 and a 200 day moving average of $8.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.